See up to 3 months of DRIO. The 7-day demo opens the 1M and 3M ranges and puts DRIO on your watchlist.
Start 7-day demoLatest DRIO insider trades
About DarioHealth Corp. (DRIO)
DarioHealth Corp. is an SEC registrant, filing under CIK 0001533998, classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
DRIO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 14,430 | $100K |
| Grant or award | 8 | 669,000 | |
| Other acquisition / disposition | 10 | 22,981 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
DRIO insider transactions (Form 4)
3020 Form 4 filings on record, the earliest from Nov 14, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 John R. Palumbo - Director | Grant or award | Common stock | 62,000 | $0.00 | - | |
 Adam K. Stern - Director | Other | Common Stock | 11,760 footnote F2 | $40.40 footnote F2 | $475K | |
| Adam K. Stern - Director | Other | Common Stock | 8,435 footnote F3 | $16.60 footnote F3 | $140K | |
| Adam K. Stern - Director | Grant or award | Common Stock | 28,000 | $0.00 | - | |
| Adam K. Stern - Director | Other | Series C Preferred Stock | 250 | $1,000.00 | $250K | |
| Adam K. Stern - Director | Other | Series D-2 Preferred Stock | 100 | $1,000.00 | $100K | |
| ||||||
| Dennis M. McGrath - Director | Grant or award | Common Stock | 61,000 | $0.00 | - | |
| Yoav Shaked - Director | Other | Common Stock | 772 footnote F2 | $19.10 footnote F2 | $15K | |
| Yoav Shaked - Director | Grant or award | Common Stock | 54,000 | $0.00 | - | |
| Yoav Shaked - Director | Other | Series B-2 Preferred Stock | 40 | $1,000.00 | $40K | |
| ||||||
| Chen Franco-Yehuda - Officer | Grant or award | Common Stock | 95,000 | $0.00 | - | |
| Dennis Matheis - Director | Grant or award | Common Stock | 44,000 | $0.00 | - | |
| Hila Karah - Director | Grant or award | Common Stock | 28,000 | $0.00 | - | |
| Erez Raphael - Officer | Other | Common Stock | 579 footnote F2 | $19.10 footnote F2 | $11K | |
| Erez Raphael - Officer | Grant or award | Common Stock | 297,000 | $0.00 | - | |
| Erez Raphael - Officer | Other | Series B-2 Preferred Stock | 30 | $1,000.00 | $30K | |
| ||||||
| Dennis Matheis - Director | Other | Series B-2 Preferred Stock | 50 | $1,000.00 | $50K | |
| Dennis Matheis - Director | Other | Common Stock | 965 footnote F2 | $19.10 footnote F2 | $18K | |
| Dennis Matheis - Director | Open-market purchase | Common Stock | 14,430 | $6.93 | $100K | |
| ||||||
| Erez Raphael - Officer | Grant or award | Common Stock | 60,000 | $0.00 | - | |
| Steven Charles Nelson - Officer | Grant or award | Common Stock | 30,000 | $0.00 | - | |
| Lawrence B. Leisure - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Yoav Shaked - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Dennis Matheis - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Chen Franco-Yehuda - Officer | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Hila Karah - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Adam K. Stern - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Dennis M. McGrath - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Steven Charles Nelson - Officer | Open-market purchase | Common Stock | 40,000 | $0.53 | $21K | |
| Steven Charles Nelson - Officer | Open-market purchase | Common Stock | 5,000 | $0.91 | $5K | |
Item 5.02
Item 5.02, 9.01
Item 1.01, 8.01, 9.01
Item 5.02
DRIO insider trading FAQ
What is the latest insider trade for DRIO?
DarioHealth Corp. (DRIO) had 9 insider filings in the last 90 days, with the most recent on 2026-09-28. The full record for DRIO runs to 20 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DRIO stock?
1 insider purchase of DRIO was filed in the last 90 days, totaling $100K.
How many insiders are selling DRIO stock?
No insider sales of DRIO were filed in the last 90 days.
Where can I see DRIO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DRIO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John R. Palumbo view on EDGAR
- - Adam K. Stern view on EDGAR
- - Dennis M. McGrath view on EDGAR
- - Yoav Shaked view on EDGAR
- - Chen Franco-Yehuda view on EDGAR
- - Dennis Matheis view on EDGAR
- - Hila Karah view on EDGAR
- - Erez Raphael view on EDGAR
- - Dennis Matheis view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where DRIO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DRIO with a 7-day demo
- DRIO on your watchlist
- Every DRIO Form 4 filing on record
- Up to 3 months of DRIO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
